drugset / Trial / NCT00092170

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

NCT00092170

Phase 2 Completed 100 enrolled Merck Sharp & Dohme LLC
RandomizedOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of an approved medication for adults for an investigational use in pediatric patients 3 months to 17 years for the treatment of complicated intra-abdominal infections or acute pelvic infections.

Timeline

Start
2002-03
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clavulanate Unknown
Subject Ertapenem Small molecule
Subject Ticarcillin Small molecule